Marchex (FRA:NHM) YoY EBITDA Growth: -112.50% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NHM Marchex Inc FRA:NHM
58 GF Score
Price €1.04
GF Value €1.46
! 3 Warning Signs
View Full Analysis

What is Marchex YoY EBITDA Growth?

Marchex FRA:NHM -9.57% 58 YoY EBITDA Growth is -112.50% as of Jun. 2026. GuruFocus rates FRA:NHM with a GF Score™ of 58/100 and a GF Value™ of €1.46. The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Marchex's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was -112.50%.

Marchex's EBITDA per Share for the three months ended in Jun. 2026 was €-0.00.

Marchex YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Marchex's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marchex YoY EBITDA Growth Chart

Marchex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 106.27 -258.14 -41.18 34.38 -22.22

Marchex Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 233.33 -160.00 -88.89 28.13 -112.50
FRA:NHM
58GF Score
Marchex Inc FRA:NHM
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marchex YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Marchex's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.077--0.063)/ | -0.063 |
=-22.22 %

Marchex's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(-0.001-0.008)/ | 0.008 |
=-112.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -112.50% mean?
Marchex (FRA:NHM) has a YoY EBITDA Growth of -112.50% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Marchex and its competitors.
Is Marchex's YoY EBITDA Growth too high?
Marchex's current YoY EBITDA Growth is -112.50%. Overall, Marchex has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Marchex's YoY EBITDA Growth compare to TJGC and TSQ?
Marchex's YoY EBITDA Growth of -112.50% can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Media - Diversified company?
A good YoY EBITDA Growth depends on the Media - Diversified industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Marchex and its competitors. Marchex's current YoY EBITDA Growth is -112.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marchex stock overvalued right now?
Marchex (FRA:NHM) has a current YoY EBITDA Growth of -112.50%. The stock's GF Value™ is €1.46, compared to a current price of €1.04 — trading 28.8% below its estimated fair value. The current YoY EBITDA Growth is -112.50%. Marchex's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Marchex (FRA:NHM), the current YoY EBITDA Growth is -112.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Marchex (FRA:NHM) Overvalued in 2026?

Based on GuruFocus' analysis, Marchex stock appears to be undervalued. The current stock price of €1.04 is trading 28.8% below its estimated GF Value™ of €1.46.

Key valuation signals for FRA:NHM:

  • YoY EBITDA Growth: -112.50%
  • GF Value™: €1.46 vs. price of €1.04 (28.8% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the FRA:NHM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Marchex Business Description

Other Exchanges MCHX:USA
Address 1200 5th Avenue, Suite 1300, Seattle, WA, USA, 98101
Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.
58GF Score

Get the complete analysis for FRA:NHM

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.04
Price
€1.46
GF Value